Abionyx Pharma Partners With Axplora for CER-001 Manufacturing

Bitget2026/10/27 06:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Abionyx Pharma entered a strategic manufacturing partnership with Axplora, completing the production network for its investigational biologic CER-001 alongside Texcell and Olon.
Axplora will purify recombinant human apoA-I, CER-001's key biological component, at its Pompey site in France.
The network supports preparations for potential initial marketing authorization in LCAT deficiency, subject to required validations.
A Phase 2b sepsis trial, RACERS 2, is being prepared following €33 million in financing secured in June 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abionyx Pharma SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261026719139) on October 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Abionyx Pharma Partners With Axplora for CER-001 Manufacturing

You may also like

Crypto prices